Global Infectious Disease Treatment Market to 2029 - Featuring Pfizer, Abbvie and Alere Among Others
April 01, 2022 06:38 ET
|
Research and Markets
Dublin, April 01, 2022 (GLOBE NEWSWIRE) -- The "Infectious Disease Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Global Infectious Disease Treatments Market Report 2021, Featuring Abbott, AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Novartis and Roche
December 24, 2021 06:23 ET
|
Research and Markets
Dublin, Dec. 24, 2021 (GLOBE NEWSWIRE) -- The "Global Markets for Infectious Disease Treatments" report has been added to ResearchAndMarkets.com's offering. The global market for infectious...
Immutep’s Phase II TACTI-002 Study Reports Encouraging Data at SITC
November 09, 2020 16:10 ET
|
Immutep Limited
Sydney, Australia, Nov. 10, 2020 (GLOBE NEWSWIRE) -- ASX/Media Release...
Immutep Announces Australian Patent Grant For IMP701 Antibody
November 09, 2020 08:00 ET
|
Immutep Limited
Sydney, Australia, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”) announces the grant of patent no. 2015229103 entitled “Antibody molecules...
OnCore Biopharma Agrees to Acquire Enantigen Therapeutics
October 01, 2014 02:00 ET
|
OnCore Biopharma, Inc.
DOYLESTOWN, Pa., Oct. 1, 2014 (GLOBE NEWSWIRE) -- OnCore Biopharma, Inc. ("OnCore" or the "Company"), a biotechnology company focused on the research, development and commercialization of oral...